Clinical Trials Directory

Trials / Unknown

UnknownNCT02782338

The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin

The Effect of Voltaren-ophtha 0.1% (Diclofenac Sodium 0.1%) Eye Drops After Cataract Surgery on INR Levels (International Normalized Ratio) in Patients Taking Warfarin

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Wolfson Medical Center · Other Government
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

A prospective study intended to examine the effect of topical Voltaren-Ophtha 0.1% eye drops after cataract surgery on INR levels (international normalized ratio) in patients taking warfarin.

Detailed description

Objective: To examine the effect of topical Voltaren-Ophtha 0.1% eye drops after cataract surgery on INR levels ( international normalized ratio) in patients taking warfarin. Methods: A prospective study. The study population will include approximately 100 patients, taking warfarin and that are candidates for cataract surgery. These patients will continue their warfarin therapy as usual and at the same dose, before and after the operation. INR levels (international normalized ratio) will be checked once a week while taking Voltaren eye drops as is customary after cataract surgery.

Conditions

Interventions

TypeNameDescription
DRUGVoltaren ophtha 0.1%All study patients will be treated with Voltaren ophtha 0.1% after cataract surgery

Timeline

Start date
2016-05-01
Primary completion
2017-05-01
Completion
2017-12-01
First posted
2016-05-25
Last updated
2016-06-01

Source: ClinicalTrials.gov record NCT02782338. Inclusion in this directory is not an endorsement.